Lexaria Bioscience Corp. (LEXX)
Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014
Balance Sheet Date2025-Nov-302024-Nov-302023-Nov-302022-Nov-302021-Nov-302020-Nov-302019-Nov-302018-Nov-302017-Nov-302016-Nov-302015-Nov-302015-Aug-312015-Feb-282014-Nov-302014-Jul-312014-Apr-30
Fiscal PeriodQ4-FY2025Q4-FY2024Q4-FY2023Q4-FY2022Q4-FY2021Q4-FY2020Q4-FY2019Q4-FY2018Q4-FY2017Q4-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q3-FY2014Q2-FY2014
Price to Sales
Price to Book3.34x2.78x6.22x2.76x4.14x3.75x5.92x3.31x6.07x3.43x2.59x.99x3.16x2.31x1.86x1.94x1.68x2.01x2.45x3.50x2.39x
Price to Earnings---------
Price to Unlevered FCF
Debt to Asset Ratio.25x.38x.23x.22x.04x.14x.03x.03x.07x.13x.23x.05x.05x.03x.02x.02x.02x.02x.03x.04x.16x.12x.04x.03x.05x.07x.04x.12x.04x.02x.03x.02x.04x.03x.03x.44x.45x.85x1.14x.73x.36x.08x.03x.35x.35x.22x.23x
Current Ratio3.68x2.32x3.90x4.24x29.64x7.18x58.27x66.29x21.63x8.03x4.01x17.94x19.04x35.96x40.09x63.86x45.86x81.18x43.78x27.41x5.39x8.53x27.79x18.65x14.68x9.86x19.71x7.28x24.86x52.34x36.11x39.76x25.26x30.27x76.98x2.41x2.28x1.18x.84x1.19x12.24x30.35x2.79x2.80x1.25x1.40x